NEWS

Health

Reuters: Lilly’s combo therapy succeeds in late-stage lung cancer study

Category: Business and Investment News

Eli Lilly and Co’s combination cancer treatment met the main goal of a late-stage clinical trial testing it on patients with a form of lung cancer, the drugmaker announced on Tuesday. Previously untreated patients with metastatic non-small cell lung cancer taking a combination of Lilly’s Cyramza and Roche’s erlotinib went longer before their disease started […]

Source: Reuters

Published: March 12, 2019


More

Dagens Medisin: Har tildelt milliardkontrakt i Helse-Midt

Category: Business and Investment News

Det amerikanske selskapet Epic Systems Corporation er som ventet tildelt kontrakten om Helseplattformen, som er verdt 2,7 miliarder. Helseplattformen i Helse Midt-Norge skal anskaffe og innføre ny, felles pasientjournal (PAS/EPJ) ved sykehus og 84 kommuner, inkludert alle fastlegene, i hele Midt-Norge. Styret i Helse Midt-Norge RHF vedtok fredag å tildele kontrakten om anskaffelsen til amerikanske Epic. Les […]

Source: Dagens Medisin

Published: February 11, 2019


More

The Top-50 biopharmaceutical investors in the world.

Business

Category: Health

The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world . These companies, based in 46 countries, invested a total of €736.4 Bn which is approximately 90% of the world’s business-funded R&D. The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn […]

Source: Health Informatics


More

Bristol-Myers kjøper Celgene for 647 milliarder kroner

Business

Category: Health

Legemiddelselskapet Bristol-Myers Squibb har inngått en avtale om å kjøpe opp bioteknologiselskapet Celgene i en avtale verdt rundt 74 milliarder dollar, tilsvarende 647 milliarder kroner. Det skriver Bristol-Myers i en børsmelding. Til sammenligning er Norges mest verdifulle selskap, Equinor, verdt 629 milliarder kroner torsdag ettermiddag. Avtalen innebærer at aksjonærene i Celgene får en aksje i […]

Source: E24


More

Abbvie: Helsenæring

Business

Category: Government

AmCham members Abbvie recently launched a magazine highlighting the advantages of an expanded and innovative research-based health industry in Norway.    

Source: Abbvie


More
Page 1 of 7
1 2 3 7